These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 16904302

  • 1. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
    Onlen Y, Tamer C, Oksuz H, Duran N, Altug ME, Yakan S.
    Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
    [Abstract] [Full Text] [Related]

  • 2. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits.
    Oksuz H, Duran N, Tamer C, Cetin M, Silici S.
    Ophthalmic Res; 2005; 37(6):328-34. PubMed ID: 16138004
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK, Kowalski RP, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [Abstract] [Full Text] [Related]

  • 5. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP, Chacko D, Kettering JD, Wessels IF, Aprecio RM.
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
    Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ.
    Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
    [Abstract] [Full Text] [Related]

  • 7. The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits.
    Duran N, Koc A, Oksuz H, Tamer C, Akaydin Y, Kozlu T, Celik M.
    Mol Cell Biochem; 2006 Jan; 281(1-2):153-61. PubMed ID: 16328968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
    Callegan MC, Hobden JA, Hill JM, Insler MS, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P, Hobden JA.
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM, Green LC, Engel LS, Hill JM, O'Callaghan RJ.
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS, Romanowski EG, Kowalski RP, Yates KA, Gordon YJ.
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.